Rtw Investments, LP Cerevel Therapeutics Holdings, Inc. Transaction History

Rtw Investments, LP

  • $6.27 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$23.5 - $35.38 $15.7 Million - $23.6 Million
-666,666 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$21.26 - $38.85 $3.54 Million - $6.47 Million
166,666 Added 33.33%
666,666 $19.7 Million
Q4 2020

Feb 16, 2021
BUY
$9.82 - $18.27 $4.91 Million - $9.14 Million
500,000 New
500,000 $8.29 Million

Others Institutions Holding CERE

# of Institutions
11
Shares Held
5.01M
Call Options Held
3.3K
Put Options Held
0
View Full List

About Cerevel Therapeutics Holdings, Inc.

CERE Quotes by TradingView
  • Ticker CERE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 155,752,000
  • Description
  • Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-...
More about CERE
Track This Portfolio

Track Rtw Investments, LP Portfolio

Follow Rtw Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rtw Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Rtw Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email